(MENAFN- EIN Presswire)
Settlements from pharmacies, combined with those from drug makers and distributors, will result in over $1 billion for the State of New Mexico's use in battling the aftermath of the opioid epidemic throughout the state.
Additional $274 million in settlements, plus amounts from distributors and manufacturers, will fuel State's opioid-crisis recovery efforts with over $1 billion. Walgreens' corporate desire for profits trumped the public's right to safety.” - JEFF GADDY, ATTORNEY, LEVIN PAPANTONIO RAFFERTYPENSACOLA, FL, UNITED STATES, June 10, 2023/einpresswire.com / -- Heavy-hitter mass torts law firm Levin Papantonio Rafferty (LPR) proudly announced a $500-million settlement agreement with Walgreens, the pharmaceutical giant accused of recklessly dispensing opioids and, in so doing, facilitating the State of New Mexico's opioid crisis (D-101-CV-201702541).
“The New Mexico settlement is one of the largest separate settlements ever obtained from a single opioid defendant in the U.S., and it is the largest Attorney General settlement in New Mexico history,” said LPR Attorney jeff gaddy , who was co-lead of the trial team along with peter mougey of Levin
Papantonio Rafferty, Dan Alberstone and Mark Pifko of Baron & Budd PC, Anthony Majestro of Powell & Majestro PLLC, and Luis Robles of Robles Rael
"Walgreens' actions cost communities in the State of New Mexico in ways that can never be recovered with a financial payout, but we have confidence that this flow of funds will help the State and its residents begin to heal," Gaddy said. Mougey remarked that the fact that the settlement agreement came after the trial, rather than before or even during trial, makes it even more notable as an achievement in civil litigation.
“The fact that Walgreens was willing to pay half a billion dollars to avoid receiving a verdict after all of the evidence had been heard illustrates the strength of the case that was offered that tied Walgreens' corporate behavior to the opioid epidemic in New Mexico,” Mougey said.
The trial counsel for the State of New Mexico was tasked with presenting evidence and arguments to convince District Judge Francis J. Mathew that Walgreens failed to implement controls over the State's supply of opioids and conduct the due diligence required to prevent diversion (the misappropriation of prescribed drugs). Specifically, Mougey, Gaddy, and the other trial co-leads argued that the pharmacy giant knowingly filled red-flagged prescriptions without investigating them, thereby opening the floodgates to permit a free flow of prescription opioids into New Mexico.
New Mexico will use the Walgreens settlement to help abate the public nuisance caused by the opioids epidemic its pharmacies facilitated throughout
The settlement news came after a two-month trial against pharmacy powerhouses Walgreens, Walmart, and Kroger. The three pharmacy giants are said to be responsible for over half the opioid pills in New Mexico, according to New Mexico Attorney General Hector Balderas, who opened the bench trial in
September 2022. During the course of the trial, Walmart and Kroger paid settlements of $150 million and $85 million, respectively. Immediately prior to trial, Albertsons settled for $20 million, and CVS paid a $19 million settlement.
The State of New Mexico will also receive a portion of a national settlement with distributor defendants in the national opioid litigation--including McKesson, Amerisource Bergen, Cardinal Health, and Johnson & Johnson--in the amount of $190 million.
The news of this New Mexico settlement comes on the heels of Walgreens, CVS, and Walmart announcing that they have finalized national settlements
with all other states and local governments across the country for over $13 billion (MDL 2804) .
“These national settlements will go a long way toward providing relief to local communities who have been hard hit by the scourge of opioid addiction these companies caused with their profit-over-safety mantras,” said Mougey, who was a key negotiator in the national deal.
Levin Papantonio Rafferty
email us here
Visit us on social media:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.